Lung Cancer News and Research

Latest Lung Cancer News and Research

Study uncovers novel drug that effectively thwarts pancreatic tumors

Pancreatic cancer is an aggressive disease in which malignant cells form in the tissues of the pancreas, a long and flat gland located behind the stomach that helps with digestion and blood sugar regulation.

14 Jun 2021

Macrophages can aid tumor growth by distracting cancer-killing CD8+ T cells

A Ludwig Cancer Research study adds to growing evidence that immune cells known as macrophages inhabiting the body cavities that house our vital organs can aid tumor growth by distracting the immune system's cancer-killing CD8+ T cells.

11 Jun 2021

Major anti-cancer protein released by neutrophils selectively kills tumor cells

A study published in the June 10, 2021 issue of Cell describes a remarkable new mechanism by which the body's own immune system can eliminate cancer cells without damaging host cells.

10 Jun 2021

LIM domain only 1 gene contributes to the tumorigenesis of multiple cancers

Humans have been plagued by a myriad of deadly cancers since ages. Parallelly, they have also been attempting different permutations and combinations of treatments to cure the disease. Part of these attempts involving biomolecular targets have come to the fore in recent years.

10 Jun 2021

KA Imaging signs Australian distributor - Regional Health Care Group

Medical distribution company Regional Health Care Group will now be bringing KA Imaging’s innovative X-ray technologies to Australia and New Zealand.

From KA Imaging 9 Jun 2021

New blood test helps monitor patient’s response to cancer treatment

Cancer patients who are undergoing targeted therapy can look forward to a new blood test that could tell their doctors whether the treatment is working, within one day after the start of the treatment.

8 Jun 2021

New drug shows promise against lung cancer caused by genetic mutation

The new drug sotorasib reduces tumor size and shows promise in improving survival among patients with lung tumors caused by a specific DNA mutation, according to results of a global phase 2 clinical trial.

8 Jun 2021

New report highlights enormous disease burden and treatment gap of osteoporosis in Europe

New International Osteoporosis Foundation report provides unique overview of osteoporosis in Europe, revealing the enormous disease burden and an unacceptable treatment gap; 71% of women at high risk of fracture are not receiving much-needed medication.

7 Jun 2021

New drug reduces tumor size in lung cancer patients who have a specific, disease-causing change

A new drug reduced tumor size in patients who have lung cancer with a specific, disease-causing change in the gene KRAS, a study found.

7 Jun 2021

SARS-CoV-2 evades neutralizing antibodies and rapidly spreads by cell fusion, finds study

In a new study by researchers in the UK, Germany and South Africa, this process is visualized using time-lapse microscopy of a human cell lung line, demonstrating that SARS-CoV-2 can induce cell-to-cell fusion within 6 hours post-infection. Further, the application of neutralizing monoclonal antibodies or convalescent plasma was unable to prevent the spread of the virus by this mechanism, suggesting that removing SARS-CoV-2 from cells permissive of cell membrane fusion could be more difficult than other types of cell.

4 Jun 2021

Study: Lung squamous patients harboring druggable mutations have lower median overall survival

Oncotarget published "Molecular characterization of lung squamous cell carcinoma tumors reveals therapeutically relevant alterations" which reported that unlike lung adenocarcinoma patients, there is no FDA-approved targeted-therapy likely to benefit lung squamous cell carcinoma patients.

3 Jun 2021

BMI may not be best obesity indicator to evaluate lung cancer risk, study suggests

New research published in the Journal of Thoracic Oncology suggests the method used to calculate how obesity is measured may affect whether it is considered a risk factor for lung cancer.

2 Jun 2021

SWOG researchers to present practice-changing research at virtual ASCO 2021

"SWOG always brings an impressive portfolio of work to the ASCO annual meeting," said SWOG Chair Charles D. Blanke, MD, "and this year I'm particularly excited about the research our investigators are presenting because it includes results that are likely to be practice-changing."

1 Jun 2021

FIRS calls on governments and policymakers to support and promote tobacco cessation services

On World No Tobacco Day (31 May, 2021) the Forum of International Respiratory Societies (FIRS), of which the American College of Chest Physicians® (CHEST) is a founding member, calls on governments and policymakers to make greater political and financial commitments to support and promote tobacco cessation services.

29 May 2021

FDA approves targeted therapy for tumors with KRAS mutations

Today, the U.S. Food and Drug Administration approved Lumakras (sotorasib) as the first treatment for adult patients with non-small cell lung cancer whose tumors have a specific type of genetic mutation called KRAS G12C and who have received at least one prior systemic therapy.

29 May 2021

Cancer risk increases with the number of cigarettes smoked per day, confirms study

Today, in advance of World No Tobacco Day, The Daffodil Centre released an Australian first study, with findings showing tobacco smoking significantly increased the risk of 12 types of cancer and that 1-in-7 current smokers will get lung cancer in their lifetime.

29 May 2021

Glycosylation a significant element in SARS-CoV-2 infection and vaccine design, says study

A new study by researchers from Taiwan and the US suggests that the removal of unnecessary glycans from spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposes highly conserved sequences and opens the door for the development of broadly protective vaccines against the virus and its variants.

28 May 2021

NFCR announces winners of 2021 Salisbury Award Competition

The National Foundation for Cancer Research (NFCR) announced winners of the 2021 Salisbury Award Competition for Entrepreneurial Translational Research, selected from among eight semi-finalists after pitch presentations in front of a judging committee consisting of prominent cancer research scientists, clinicians, early-stage investors and business leaders.

26 May 2021

KA Imaging signs with Alpha Imaging for distribution in the USA

KA Imaging has signed a distribution agreement in the USA with Alpha Imaging.

From KA Imaging 25 May 2021

FDA approves Rybrevant for treating subset of non-small cell lung cancer

Today, the U.S. Food and Drug Administration approved Rybrevant (amivantamab-vmjw) as the first treatment for adult patients with non-small cell lung cancer whose tumors have specific types of genetic mutations: epidermal growth factor receptor (EGFR) exon 20 insertion mutations.

21 May 2021

Lung Cancer News and Research

Latest Lung Cancer News and Research

Study uncovers novel drug that effectively thwarts pancreatic tumors

Macrophages can aid tumor growth by distracting cancer-killing CD8+ T cells

Major anti-cancer protein released by neutrophils selectively kills tumor cells

LIM domain only 1 gene contributes to the tumorigenesis of multiple cancers

KA Imaging signs Australian distributor - Regional Health Care Group

New blood test helps monitor patient’s response to cancer treatment

New drug shows promise against lung cancer caused by genetic mutation

New report highlights enormous disease burden and treatment gap of osteoporosis in Europe

New drug reduces tumor size in lung cancer patients who have a specific, disease-causing change

SARS-CoV-2 evades neutralizing antibodies and rapidly spreads by cell fusion, finds study

Study: Lung squamous patients harboring druggable mutations have lower median overall survival

BMI may not be best obesity indicator to evaluate lung cancer risk, study suggests

SWOG researchers to present practice-changing research at virtual ASCO 2021

FIRS calls on governments and policymakers to support and promote tobacco cessation services

FDA approves targeted therapy for tumors with KRAS mutations

Cancer risk increases with the number of cigarettes smoked per day, confirms study

Glycosylation a significant element in SARS-CoV-2 infection and vaccine design, says study

NFCR announces winners of 2021 Salisbury Award Competition

KA Imaging signs with Alpha Imaging for distribution in the USA

FDA approves Rybrevant for treating subset of non-small cell lung cancer

The ultimate guide to lung research tools and protocols eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Lung Cancer News and Research

Latest Lung Cancer News and Research

The ultimate guide to lung research tools and protocols eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in